---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-067481"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2023-12-04T23:59:59+00:00"
generated_at: "2026-06-07T18:46:30.635185+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Iterum regains Nasdaq compliance with minimum bid price rule

## Summary
- Received letter from Nasdaq on Dec 4, 2023 confirming compliance with Bid Price Rule.
- Previously notified of deficiency on Sept 26, 2023; compliance deadline was March 25, 2024.
- Achieved minimum $1.00 closing bid price for 10 consecutive trading days through Nov 30, 2023.

## SEC filing metadata
- accession: 0000950170-23-067481
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2023-12-04T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000095017023067481/0000950170-23-067481-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000095017023067481/itrm-20231204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-067481
- JSON: https://secwatch.observer/filing/0000950170-23-067481.json
- Plain text: https://secwatch.observer/filing/0000950170-23-067481.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.